SCHEMBL5259174

SCHEMBL5259174

COc1cc2c(O)nc(-c3ccc(Cl)cc3)nc2c(OC)c1OC

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 3/20 0.44
THRB P10828 1/20 0.42
DHPS P49366 2/20 0.41
CXCL12 P48061 1/20 0.41
MAPT P10636 2/20 0.41
LMNA P02545 1/20 0.41
EGFR P00533 3/20 0.40
PDGFRB P09619 1/20 0.40
JAK2 O60674 1/20 0.40
CDK2 P24941 1/20 0.40
PIK3CA P42336 1/20 0.40
PIK3CB P42338 1/20 0.40
PIK3CG P48736 1/20 0.40
PTK2B Q14289 1/20 0.40
TP53 P04637 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5263213 0.86 DHPS (0.49) PDE5ATHRBDHPSMAPTLMNA
SCHEMBL5258730 0.81 WHR1 (0.52) THRBCXCL12LMNAEGFRPDGFRB
SCHEMBL7268608 0.78 PDE5A (0.51) PDE5ATHRBDHPSMEN1KMT2A
SCHEMBL5258158 0.78 GAA (0.40) PDE5AEGFRCDK2SMN1; SMN2
Hydrochloric Acid SCHEMBL7262070 0.78 PDE5A (0.50) PDE5ATHRBMEN1KMT2A
SCHEMBL7261425 0.77 PDE1B (0.60) PDE5ATHRBDHPSLMNAEGFR
SCHEMBL11213463 0.76 PDE5A (0.49) PDE5AMAPT
SCHEMBL7266347 0.76 MEN1 (0.53) PDE5ATHRBMAPTLMNATP53
SCHEMBL8134950 0.76 KDM4E (0.43) PDE5AMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL8068659 0.75 ALDH1A1 (0.47) MAPTLMNATP53SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040101-B1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS SANOFI AVENTIS DEUTSCHLAND (DE) 2007-04-25 EP disclosed
US-6613772-B1 Drugs such as 2-(p-chlorophenyl-4-(4-hydroxybutyl)amino-6,7,8 -trimethoxyquinazoline used for activation of guanylate cyclase and modulation of cyclic guanosine monophosphate AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-09-02 US disclosed
EP-1040101-A1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS Aventis Pharma Deutschland GmbH (DE) 2000-10-04 EP disclosed
WO-1999032460-A1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 1999-07-01 WO disclosed